United States · FDA National Drug Code directory
Gabapentin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 65862-199_7a45ad84-02a4-442d-8401-1a1495d084fa
- Product NDC
- 65862-199
- Form
- CAPSULE
- Composition / generic term
- Gabapentin
- Labeler
- Aurobindo Pharma Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20080131
- Source listing expiry
- 20261231
Source-listed ingredients
- GABAPENTIN — 300 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE in 1 BOTTLE (65862-199-01) · 65862-199-01
- 500 CAPSULE in 1 BOTTLE (65862-199-05) · 65862-199-05
- 10 BLISTER PACK in 1 CARTON (65862-199-10) / 10 CAPSULE in 1 BLISTER PACK · 65862-199-10
- 180 CAPSULE in 1 BOTTLE (65862-199-18) · 65862-199-18
- 270 CAPSULE in 1 BOTTLE (65862-199-27) · 65862-199-27
- 30 CAPSULE in 1 BOTTLE (65862-199-30) · 65862-199-30
- 60 CAPSULE in 1 BOTTLE (65862-199-60) · 65862-199-60
- 90 CAPSULE in 1 BOTTLE (65862-199-90) · 65862-199-90
- 1000 CAPSULE in 1 BOTTLE (65862-199-99) · 65862-199-99
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →